Weitere Artikel dieser Ausgabe durch Wischen aufrufen
Assessment of patients receiving treatment for human immunodeficiency virus (HIV) and tuberculosis (TB) using a Health Related Quality of Life (HRQoL) instrument is important to get the subjective view of the patients’ wellbeing.
We used the Functional Assessment of HIV Infection (FAHI) HRQoL instrument to collect perceived wellness information at baseline, month 3, 6 and 12 from patients enrolled in a pharmacokinetic study between March 2007 and April 2008. Composite domain scores at each time point and their relationship with the rate of adverse events (AEs) and serious adverse events were compared between treatment arms.
Out of the 82 patients enrolled, 76 were analysed. There was a significant increase in total score in all groups between baseline, month 3, 6 and 12 (all p values < 0.0001), and over time (p < 0.001). Adjusting for baseline total score, baseline CD4 count had a significant effect on the total score over time (p = 0.002) and the rate of change in total score over time, that is; interaction effect (p < 0.001). There was no difference in each domain scores between participants that received ART with TB treatment and those that received TB treatment only. Respiratory AEs had a significant effect on HRQoL.
We found that assessment of HRQoL of participants in TB–HIV treatment using the FAHI instrument was useful in evaluating treatment responses. It showed improvement consistent with decrease in adverse events and signs and symptoms of TB. Number and type of AEs was related to lower HRQoL in spite of TB cure.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Kaplan, R. M., & Bush, J. W. (1982). Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology, 1(1), 61. CrossRef
Mekasha, T. & Woldemichael, K. (2009). Assessment of patients’ health related quality of life during tuberculosis treatment as compared to their neighbours in Hawassa town, Ethiopia. Master’s thesis in public health.
Duyan, B., et al. (2005). Relationship between quality of life and characteristics of patients hospitalized with tuberculosis. The International Journal of Tuberculosis and Lung Disease, 9(12), 1361–1366. PubMed
Dhuria, M., Sharma, N., & Ingle, G. (2008). Impact of tuberculosis on the quality of life. Indian journal of community medicine: official publication of Indian Association of Preventive & Social Medicine, 33(1), 58. CrossRef
Mutimura, E., Stewart, A., & Crowther, N. (2007). Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda. AIDS Research and Therapy, 4(19), 1–8.
Campsmith, M. L., Nakashima, A. K., & Davidson, A. J. (2003). Self-reported health-related quality of life in persons with HIV infection: Results from a multi-site interview project. Health Quality Life Outcomes, 1, 12. CrossRef
Gill, C. J., et al. (2002). Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. Journal of acquired immune deficiency syndromes (1999), 30(5), 485–492. CrossRef
McInerney, P. (2008). Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nursing & Health Sciences, 10(4), 266–272. CrossRef
Louw, J., et al. (2012). Quality of life among tuberculosis (TB), TB retreatment and/or TB–HIV co-infected primary public health care patients in three districts in South Africa. Health Quality Life Outcomes, 10(77), 1477–7525.
World Health Organization. (2013). Global tuberculosis report 2013. Geneva, Switzerland: WHO, HTM/TB.
WHO. (2014). Global Tuberculosis Report 2014. World Health Organization.
Godfrey-Faussett, P., et al. (2002). How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bulletin of the World Health Organization, 80(12), 939–945. PubMed
Yee, D., et al. (2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. American Journal of Respiratory and Critical Care Medicine, 167, 603–662. CrossRef
Verbeke, G., & Molenberghs, G. (2009). Linear mixed models for longitudinal data. New YorK: Springer.
Timilsina, S., & Regmi, K. (2015). Assessing quality of life and depression among people living with HIV/AIDS and TB–HIV coinfection in Kathmandu, Nepal. SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, 11(2), 7–14. CrossRef
Akinboro, A.O., et al. (2014). Quality of life of Nigerians living with human immunodeficiency virus. The Pan African Medical Journal, 18, 234.
Deribew, A., et al. (2013). Change in quality of life: A follow up study among patients with HIV infection with and without TB in Ethiopia. BMC Public Health, 13(408), 1471–2458.
Venter, E., Gericke, G., & Bekker, P. (2009). Nutritional status, quality of life and CD4 cell count of adults living with HIV/AIDS in the Ga-Rankuwa area (South Africa): Original research. South African Journal of Clinical Nutrition, 3, 124–129. CrossRef
- Longitudinal assessment of health related quality of life of HIV infected patients treated for tuberculosis and HIV in a high burden setting
- Springer International Publishing
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta